These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33110524)
1. Addressing methodological and ethical issues in practicing health economic evaluation in China. Jiang S; Chen Z; Wu J; Zang X; Jiang Y J Glob Health; 2020 Dec; 10(2):020322. PubMed ID: 33110524 [No Abstract] [Full Text] [Related]
2. Estimating the marginal cost of a life year in Sweden's public healthcare sector. Siverskog J; Henriksson M Eur J Health Econ; 2019 Jul; 20(5):751-762. PubMed ID: 30796552 [TBL] [Abstract][Full Text] [Related]
3. Weighing Costs and Benefits in the Economics of Cancer Care. Ramsey SD; Dusetzina SB J Clin Oncol; 2020 Feb; 38(4):289-291. PubMed ID: 31804863 [No Abstract] [Full Text] [Related]
4. Industry sponsored bias in cost effectiveness analyses. John-Baptiste A; Bell C BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724 [No Abstract] [Full Text] [Related]
5. Competition in the healthcare sector: a missing dimension. Zweifel P Eur J Health Econ; 2017 Mar; 18(2):135-138. PubMed ID: 27502511 [No Abstract] [Full Text] [Related]
6. An Economic Analysis and Approach for Health Care Preparedness in a Substate Region. Stryckman B; Grace TL; Schwarz P; Marcozzi D Disaster Med Public Health Prep; 2015 Aug; 9(4):344-8. PubMed ID: 25896216 [TBL] [Abstract][Full Text] [Related]
7. SADA communique. Competition Commission. Smit M SADJ; 2013 Jun; 68(5):204. PubMed ID: 23971284 [No Abstract] [Full Text] [Related]
8. Economic gains from electronic message exchange: the importance of working procedures. Aanesen M; Moilanen M; Olsen F Int J Med Inform; 2010 Sep; 79(9):658-67. PubMed ID: 20621553 [TBL] [Abstract][Full Text] [Related]
9. A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures. Chambers J; Pope E; Bungay K; Cohen J; Ciarametaro M; Dubois R; Neumann PJ Value Health; 2018 Apr; 21(4):400-406. PubMed ID: 29680096 [TBL] [Abstract][Full Text] [Related]
10. Market watch: Evolution of Chinese bioclusters as a framework for investment policies in emerging markets. Gautam A Nat Rev Drug Discov; 2015 Jan; 14(1):8. PubMed ID: 25503337 [No Abstract] [Full Text] [Related]
12. Health care employment and the current economic recession. Fraher E; Carpenter J; Broome S N C Med J; 2009; 70(4):331-6. PubMed ID: 19835251 [No Abstract] [Full Text] [Related]
13. Overdue consolidation: the author replies. Vladeck BC Health Aff (Millwood); 2014 Aug; 33(8):1490. PubMed ID: 25092856 [No Abstract] [Full Text] [Related]
14. Price adjustment in the hospital sector. Miraldo M; Siciliani L; Street A J Health Econ; 2011 Jan; 30(1):112-25. PubMed ID: 20952080 [TBL] [Abstract][Full Text] [Related]
15. Economic wear and tear. Despite growth, industry feeling the strain. Evans M Mod Healthc; 2011 Sep; 41(37):8-9. PubMed ID: 21995200 [No Abstract] [Full Text] [Related]
16. Ethical Study on the Reform and Development of Medical and Health Services in China. Yang TW; Li EC Bioethics; 2015 Jul; 29(6):406-12. PubMed ID: 25395061 [TBL] [Abstract][Full Text] [Related]
17. Private healthcare market may be anti-competitive with poor returns for patients. Hawkes N BMJ; 2012 Apr; 344():e2606. PubMed ID: 22492116 [No Abstract] [Full Text] [Related]
18. Estimating a constant WTP for a QALY-a mission impossible? Sund B; Svensson M Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914 [TBL] [Abstract][Full Text] [Related]
19. Markets, Prices, And Incentives. Weil AR Health Aff (Millwood); 2015 Jun; 34(6):902. PubMed ID: 26056192 [No Abstract] [Full Text] [Related]
20. Pain and profit. The healthcare industry thrives, but many Americans struggle. McLaughlin N Mod Healthc; 2012 Jun; 42(25):18. PubMed ID: 22849259 [No Abstract] [Full Text] [Related] [Next] [New Search]